18 February 2021

Recent advances in DNA sequencing technologies have made it possible to uncover the causes of multiple rare diseases. A study co-directed by Alexandre Reymond (University of Lausanne), Simon Fisher (Max Planck Institute for Psycholinguistics) and Lisenka Vissers (Radboudumc) published online January 28, 2021 by The American Journal of Human Genetics describes how three classes of mutation within the same gene result in different neurodevelopmental disorders.

An international network of geneticists

The identification of causal variants in rare genetic diseases has been facilitated by the advent of high-throughput sequencing technologies. “We can now precisely define the region of the genome associated with a disease”, says study co-leader Lisenka Vissers from Radboud University, Nijmegen, The Netherlands.

A collaborative effort that brings together geneticists and clinicians from twelve countries on four continents allowed identification of 42 patients with mutations in a gene named SATB1. It encodes the information to produce a protein that can bind DNA and diminish the expression of other genes.

Three classes of mutation

The DNA variants found in the genome of these patients belong to three different classes. “We could investigate the impacts of each distinct type of mutation in human cells that we grow in the lab” notes study co-leader Simon Fisher from the Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands. The first class of mutations, identified in eight patients, encompasses DNA variants that destroy the function of the SATB1 gene and halve the production of the encoded protein. The second contains four mutations, which encode shorter proteins that are less efficient as they are not located correctly in the cell. The third class encompasses the mutations found in the last thirty patients. These mutations modify the encoded protein making it more active. This altered protein is “sticky” and binds better to DNA, thus diminishing the expression of genes it regulates.

Different symptoms

The geneticists uncovered that these three modes of action were associated to different neurodevelopmental disorders. The proteins that are functioning "too well" cause a severe intellectual disability often associated with epilepsy, a motor speech disorder and distinctive facial features. The lack of protein is associated with reduced cognitive functions (but less severe) and visual problems. The patients with mutations that produce shorter and mislocalised proteins show an intermediate syndrome.

Beyond sequencing

These results demonstrate that each mutation is different and that it is essential to understand their modes of action to elucidate the origin of genetic diseases. “We must go beyond DNA sequencing, which is only a first step”, concludes study co-leader Alexandre Reymond, University of Lausanne, Switzerland.


Alexandre Reymond, alexandre.reymond@unil.ch

Simon Fisher, Simon.Fisher@mpi.nl

Lisenka Vissers, Lisenka.Vissers@radboudumc.nl

Related news items

Dutch Research Agenda (NWA) WECOM grant from NWO for Martine Hoogman en Jeanette Mostert

5 July 2022 ​Martine Hoogman and Jeanette Mostert have obtained an NWA science communication grant (50k) for their ADHDplaza project. read more

Scientists find that the impact of social media on wellbeing varies across adolescence

29 March 2022 Girls and boys might be more vulnerable to the negative effects of social media use at different times during their adolescence, say an international team of scientists in a study published today in Nature Communications. read more

Rogier Kievit and Geert Litjens both receive ERC Starting Grant of 1.5 million euros Board of Directors congratulates researchers on top grant

13 January 2022 Researchers Rogier Kievit and Geert Litjens were today festively welcomed by the Board of Directors, because of the ERC Starting Grants they both received. With these European top grants, they can each design an ambitious research project and put together their own research group. read more

KNAW Early Career Award for Martine Hoogman

2 December 2021 Martine Hoogman has been awarded a KNAW Early Career Award. The prize, a sum of 15,000 euros and a work of art, is aimed at researchers in the Netherlands who are at the start of their careers and have innovative, original research ideas. read more

The Effects of Intermittent Fasting on Brain and Cognitive Function

10 November 2021 Intermittent Fasting is a type of diet in which one refrains from eating for periods of time. It is known that it has positive effects on metabolic health, but what is the effect of this diet on brain and cognition? Radboudumc researchers reviewed experimental evidence on this topic. read more

BRAINMODEL: precision medicine for brain disorders

3 November 2021 A team of researchers is going to look for new and better ways to heal developmental disorders in the brain. Six different knowledge institutions are to collaborate with civil societies, professional associations and companies on new stem cell-based methods in a project entitled ‘BRAINMODEL’. read more